Table 1.
END POINT |
PATIENTS, N (%)
|
EFFECT RELATIVE (95% CI)* | ABSOLUTE NO. PER 1 000 000 (95% CI) | |
---|---|---|---|---|
KQ1 SCREENING (N = 69 942) | CONTROL, NO SCREENING (N = 75 499) | |||
Composite | 1951 (2.8)† | 2275 (3.0)† | RR 0.91 (0.86 to 0.97) | 2712 fewer (904 fewer to 4219 fewer) |
Acute myocardial infarction | 667 (1.0)† | 816 (1.1)† | RR 0.87 (0.79 to 0.97) | 1405 fewer (324 fewer to 2270 fewer) |
Congestive heart failure | 735 (1.1)† | 923 (1.2)† | RR 0.90 (0.81 to 0.99) | 1223 fewer (122 fewer to 2323 fewer) |
Stroke | 550 (0.8)† | 536 (0.7)† | RR 0.99 (0.88 to 1.12) | 71 fewer (852 fewer to 852 more) |
All-cause mortality | 2377 (3.4)‡ | 2608 (3.5)‡ | RR 0.98 (0.92 to 1.04) | 684 fewer (2618 fewer to 1368 more) |
KQ1—key question 1, RCT—randomized controlled trial, RR—relative risk.
These outcomes represent the effect of the Cardiovascular Health Awareness Program. Outcome measures reported have been adjusted for hospital admission rates in the year before the intervention.
Calculations based on mean cumulative admissions.
Calculations based on the number of unique admissions.
Data from Kaczorowski et al.15